Allogene Therapeutics Inc (ALLO) financials · $258.1M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Allogene Therapeutics Inc (ALLO) $258.1M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | N/A | $22.0K |
| Operating Income | -$209.3M | -$273.2M |
| Net Income | -$190.9M | -$257.6M |
| EPS (Diluted) | -$0.87 | -$1.32 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $415.9M | $548.7M |
| Current Assets | $257.7M | $303.4M |
| Cash & Equivalents | $51.7M | $75.2M |
| PP&E | $72.8M | $86.1M |
| Total Liabilities | $123.4M | $126.5M |
| Current Liabilities | $32.5M | $35.5M |
| Shareholders' Equity | $292.5M | $422.2M |
| Retained Earnings | -$2.01B | -$1.82B |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$149.2M | -$200.3M |
| CapEx | $386.0K | $694.0K |
| Investing Cash Flow | $95.6M | $75.7M |
| Financing Cash Flow | $30.2M | $116.7M |
| Net Change in Cash | -$23.5M | -$7.94M |
| Free Cash Flow | -$149.6M | -$201.0M |
FAQ
What is ALLO P/E and revenue?
Allogene Therapeutics Inc (ALLO) $258.1M cap.
What is ALLO revenue?
ALLO income-statement cache has no revenue figure yet.
Is ALLO profitable?
Allogene Therapeutics Inc last cached net income is -$190.9M (FY2025).
What are ALLO total assets?
Allogene Therapeutics Inc last cached total assets are $415.9M (FY2025).
What is ALLO free cash flow?
Allogene Therapeutics Inc last cached free cash flow is -$149.6M (FY2025).
Not investment advice. Cached statements, not a live tape.